These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11412300)

  • 1. Siglecs in the immune system.
    Crocker PR; Varki A
    Immunology; 2001 Jun; 103(2):137-45. PubMed ID: 11412300
    [No Abstract]   [Full Text] [Related]  

  • 2. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglecs and their roles in the immune system.
    Crocker PR; Paulson JC; Varki A
    Nat Rev Immunol; 2007 Apr; 7(4):255-66. PubMed ID: 17380156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs.
    Nitschke L; Floyd H; Crocker PR
    Scand J Immunol; 2001 Mar; 53(3):227-34. PubMed ID: 11251878
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
    Cornall RJ; Goodnow CC; Cyster JG
    Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
    [No Abstract]   [Full Text] [Related]  

  • 9. B cell inhibitory receptors and autoimmunity.
    Pritchard NR; Smith KG
    Immunology; 2003 Mar; 108(3):263-73. PubMed ID: 12603592
    [No Abstract]   [Full Text] [Related]  

  • 10. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 11. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
    McMillan SJ; Crocker PR
    Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-receptors of B lymphocytes.
    O'Rourke L; Tooze R; Fearon DT
    Curr Opin Immunol; 1997 Jun; 9(3):324-9. PubMed ID: 9203413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioweapons of tumor mass destruction?
    Dyer MJ
    J Clin Oncol; 2003 Aug; 21(16):3011-2. PubMed ID: 12837808
    [No Abstract]   [Full Text] [Related]  

  • 15. The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.
    Kelm S; Schauer R; Crocker PR
    Glycoconj J; 1996 Dec; 13(6):913-26. PubMed ID: 8981082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siglecs as positive and negative regulators of the immune system.
    Crocker PR; Redelinghuys P
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1467-71. PubMed ID: 19021577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
    Engel P; Wagner N; Miller AS; Tedder TF
    J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.
    Jin L; McLean PA; Neel BG; Wortis HH
    J Exp Med; 2002 May; 195(9):1199-205. PubMed ID: 11994425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglecs as targets for therapy in immune-cell-mediated disease.
    O'Reilly MK; Paulson JC
    Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bar Mitzvah for B-1 cells: how will they grow up?
    Tarakhovsky A
    J Exp Med; 1997 Mar; 185(6):981-4. PubMed ID: 9091589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.